红白血病——骨髓增生异常综合征的一种亚型?.DOCVIP

红白血病——骨髓增生异常综合征的一种亚型?.DOC

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
临床医学论文-红白血病——骨髓增生异常综合征的一种亚型? ???????????? 作者:牛奕,陈书长, 江滨,李德高, 葛昌文,李蓉生 【摘要】?   为了研究红白血病是否为急性髓细胞白血病一个独立亚型,从临床实验及病程进展方面对21例红白血病患者进行了分析。结果显示,诊断时患者合并白细胞减少、贫血和血小板减少者分别为42.9%、81%、81%。外周血分类显示85.7%患者有幼稚粒细胞和幼稚单核细胞,52.4%患者有幼稚红细胞和有核红细胞;骨髓涂片显示骨髓增生活跃或明显活跃;红系细胞占58.3±8.0%,原始粒细胞占NEC 58.0±18.4%;66.7%患者有病态造血,与典型AML不同。在病程中52.4%患者发生疾病转型,转为RAEB/RAEBT和AMLM2,19例在确诊M6后接受化疗,11例有效(57.9%),其中CR 10例、PR 1例,CR中位维持6个月、PR 2个月,但CR患者绝大多数伴有骨髓病态造血,外周血细胞减少。中数生存期在初诊M6和MDS转化为M6组分别为13.0±13.3和2.3±1.3月。结论:临床诊断急性红白血病与典型AML有许多差异,可能大部分是以红系过度增生为表现的MDS RAEB和RAEBT型。 【关键词】? 红白血病; 急性髓性白血病; 骨髓增生异常综合症   Erythroleukemia ——A Subtype of Myelodysplastic Syndrome? ??? Abstract??? In order to study whether erythroleukemia was? really a subtype of acute leukemia, the clinical laboratory characteristics and development of disease in 21 cases of erythroleukemia were analyzed.?? The results indicated that the percentage of patients with leucocytopenia, anemia and thrombocytopenia were 42.9%, 81% and 81% respectively at the time of diagnosis. These were 85.7% of patients with myelocytes and premonocyte,? 52.4% of patients with erythroblast in their blood smear respectively. All of the bone marrow showed active or significantly active proliferation. The median percentage of erythrolineage, myeloblast of NEC and displasia were (58.3±8.0)%, (58.0±18.4)% and 66.7% respectively, that? is different from typical AML.? 52.4% of M6 patients transferred to RAEB/RAEBT and AMLM2 subtype in the disease progression. 11/19 cases (57.4%) achieved remission (CR 10; PR 1)?? after? chemotherapy. The median remission?? length? were 6? months for? CR patients and 2 months for PR patients, but most of CR patients? displayed obvious displasia of bone marrow and cytopenia of blood? in the period of CR. The median survival length of M6 and MDS→M6 from? time of diagnosis were 13.0±13.2 and 2.3±1.3 months respectively. It is concluded that there are differences between M6 and typical AML. Most of M6 patients would rather be classified MDS RAEB and RA

文档评论(0)

fengyu11 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档